Lesional Markers and Precursors of Melanoma
- PMID: 40581420
- DOI: 10.1016/j.det.2025.03.007
Lesional Markers and Precursors of Melanoma
Abstract
Melanoma is a malignant skin tumor with increasing global incidence, driven by factors like UV exposure and genetic predisposition. Early detection is critical, with markers such as atypical nevi and lentigo maligna indicating potential melanoma progression. Genetic mutations (eg, CDKN2A, NRAS) influence melanoma risk and tumor behavior, aiding risk assessment and targeted treatments. Dermoscopic and histologic tools, including the ABCDE criteria and biomarkers like S100B, improve diagnostic accuracy. Timely intervention, along with advancements in genetic testing, dermoscopy, and AI-assisted tools, are essential for reducing melanoma's morbidity and mortality. Regular surveillance for high-risk individuals is crucial for early identification and treatment.
Keywords: Atypical nevi; Lesional marker of melanoma; Melanocytic nevi; Precursor of melanoma.
Copyright © 2025 Elsevier Inc. All rights reserved.
Conflict of interest statement
Disclosures The authors have nothing to disclose.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
